FDA Accepts NDA for Glaukos’ Corneal Cross-Linking Drug Treatment
Glaukos’ Epioxa eyes FDA approval as the first non-invasive cross-linking therapy for keratoconus. Glaukos Corporation (California, USA) announced yesterday that…
Glaukos Submits NDA for Non-Invasive Keratoconus Treatment
The candidate for FDA approval is an epi-on evolution of their previous iLink procedure. Glaukos Corporation (California, USA) has announced…
latest posts
